MANNKIND CORP Stock-Based Compensation
MANNKIND CORP (MNKD) reported Stock-Based Compensation of $16.68 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-05
- MANNKIND CORP share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $10.23M, a 35.98% increase year-over-year.
- MANNKIND CORP share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $6.46M, a 19.87% increase year-over-year.
- MANNKIND CORP share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $6.97M, a 19.83% increase year-over-year.
- MANNKIND CORP share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $4.32M, a 17.39% decline year-over-year.
- MANNKIND CORP share-based payment arrangement, noncash expense for fiscal 2025 was $24.20M, a 13.28% increase from fiscal 2024.
- MANNKIND CORP share-based payment arrangement, noncash expense for fiscal 2024 was $21.36M, a 21.02% increase from fiscal 2023.
- MANNKIND CORP share-based payment arrangement, noncash expense for fiscal 2023 was $17.65M, a 31.25% increase from fiscal 2022.
- MANNKIND CORP share-based payment arrangement, noncash expense for fiscal 2022 was $13.45M, a 10.22% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month | Share-based Payment Arrangement, Noncash Expense 244 month | Share-based Payment Arrangement, Noncash Expense 247 month | Share-based Payment Arrangement, Noncash Expense 250 month | Share-based Payment Arrangement, Noncash Expense 253 month | Share-based Payment Arrangement, Noncash Expense 256 month | Share-based Payment Arrangement, Noncash Expense 259 month | Share-based Payment Arrangement, Noncash Expense 263 month | Share-based Payment Arrangement, Noncash Expense 265 month | Share-based Payment Arrangement, Noncash Expense 268 month | Share-based Payment Arrangement, Noncash Expense 271 month | Share-based Payment Arrangement, Noncash Expense 275 month | Share-based Payment Arrangement, Noncash Expense 277 month | Share-based Payment Arrangement, Noncash Expense 280 month | Share-based Payment Arrangement, Noncash Expense 283 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $10.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $16.68M 10-Q · filed 2026-08-05 | $23.65M derived: sum of 3 quarters · filed 2026-08-05 | $27.97M derived: sum of 4 quarters · filed 2026-08-05 | ||||||||||||||
| 2026-03-31 | $6.46M 10-Q · filed 2026-05-06 | $13.43M derived: sum of 2 quarters · filed 2026-05-06 | $17.75M derived: sum of 3 quarters · filed 2026-05-06 | $25.27M derived: sum of 4 quarters · filed 2026-08-05 | ||||||||||||||
| 2025-12-31 | $6.97M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $11.29M derived: sum of 2 quarters · filed 2026-02-26 | $18.81M derived: sum of 3 quarters · filed 2026-08-05 | $24.20M 10-K · filed 2026-02-26 | ||||||||||||||
| 2025-09-30 | $4.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $11.84M derived: sum of 2 quarters · filed 2026-08-05 | $17.22M 10-Q · filed 2025-11-05 | $23.04M derived: sum of 4 quarters · filed 2026-08-05 | ||||||||||||||
| 2025-06-30 | $7.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $12.90M 10-Q · filed 2026-08-05 | $18.72M derived: sum of 3 quarters · filed 2026-08-05 | $23.95M derived: sum of 4 quarters · filed 2026-08-05 | ||||||||||||||
| 2025-03-31 | $5.38M 10-Q · filed 2026-05-06 | $11.20M derived: sum of 2 quarters · filed 2026-05-06 | $16.43M derived: sum of 3 quarters · filed 2026-05-06 | $22.86M derived: sum of 4 quarters · filed 2026-05-06 | ||||||||||||||
| 2024-12-31 | $5.82M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $11.04M derived: sum of 2 quarters · filed 2026-02-26 | $17.47M derived: sum of 3 quarters · filed 2026-02-26 | $21.36M 10-K · filed 2026-02-26 | ||||||||||||||
| 2024-09-30 | $5.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $11.65M derived: sum of 2 quarters · filed 2025-11-05 | $15.54M 10-Q · filed 2025-11-05 | $19.35M derived: sum of 4 quarters · filed 2026-02-26 | ||||||||||||||
| 2024-06-30 | $6.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $10.31M 10-Q · filed 2025-08-06 | $14.13M derived: sum of 3 quarters · filed 2026-02-26 | $18.73M derived: sum of 4 quarters · filed 2026-02-26 | ||||||||||||||
| 2024-03-31 | $3.88M 10-Q · filed 2025-05-08 | $7.70M derived: sum of 2 quarters · filed 2026-02-26 | $12.30M derived: sum of 3 quarters · filed 2026-02-26 | $17.88M derived: sum of 4 quarters · filed 2026-02-26 | ||||||||||||||
| 2023-12-31 | $3.81M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $8.41M derived: sum of 2 quarters · filed 2026-02-26 | $13.99M derived: sum of 3 quarters · filed 2026-02-26 | $17.65M 10-K · filed 2026-02-26 | ||||||||||||||
| 2023-09-30 | $4.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $10.18M derived: sum of 2 quarters · filed 2024-11-07 | $13.84M 10-Q · filed 2024-11-07 | $16.43M derived: sum of 4 quarters · filed 2025-02-26 | ||||||||||||||
| 2023-06-30 | $5.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $9.23M 10-Q · filed 2024-08-07 | $11.83M derived: sum of 3 quarters · filed 2025-02-26 | $15.45M derived: sum of 4 quarters · filed 2025-02-26 | ||||||||||||||
| 2023-03-31 | $3.65M 10-Q · filed 2024-05-08 | $6.25M derived: sum of 2 quarters · filed 2025-02-26 | $9.87M derived: sum of 3 quarters · filed 2025-02-26 | $14.30M derived: sum of 4 quarters · filed 2025-02-26 | ||||||||||||||
| 2022-12-31 | $2.60M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $6.22M derived: sum of 2 quarters · filed 2025-02-26 | $10.64M derived: sum of 3 quarters · filed 2025-02-26 | $13.45M 10-K · filed 2025-02-26 | ||||||||||||||
| 2022-09-30 | $3.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $8.04M derived: sum of 2 quarters · filed 2023-11-07 | $10.85M 10-Q · filed 2023-11-07 | $14.01M derived: sum of 4 quarters · filed 2024-02-27 | ||||||||||||||
| 2022-06-30 | $4.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $7.23M 10-Q · filed 2023-08-07 | $10.39M derived: sum of 3 quarters · filed 2024-02-27 | $13.57M derived: sum of 4 quarters · filed 2024-02-27 | ||||||||||||||
| 2022-03-31 | $2.81M 10-Q · filed 2023-05-09 | $5.97M derived: sum of 2 quarters · filed 2024-02-27 | $9.14M derived: sum of 3 quarters · filed 2024-02-27 | $13.07M derived: sum of 4 quarters · filed 2024-02-27 | ||||||||||||||
| 2021-12-31 | $3.16M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $6.34M derived: sum of 2 quarters · filed 2024-02-27 | $10.27M derived: sum of 3 quarters · filed 2024-02-27 | $12.20M 10-K · filed 2024-02-27 | ||||||||||||||
| 2021-09-30 | $3.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $7.11M derived: sum of 2 quarters · filed 2022-11-08 | $9.04M 10-Q · filed 2022-11-08 | $10.94M derived: sum of 4 quarters · filed 2023-02-23 | ||||||||||||||
| 2021-06-30 | $3.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $5.86M 10-Q · filed 2022-08-09 | $7.76M derived: sum of 3 quarters · filed 2023-02-23 | $9.06M derived: sum of 4 quarters · filed 2023-02-23 | ||||||||||||||
| 2021-03-31 | $1.94M 10-Q · filed 2022-05-05 | $3.84M derived: sum of 2 quarters · filed 2023-02-23 | $5.13M derived: sum of 3 quarters · filed 2023-02-23 | $7.32M derived: sum of 4 quarters · filed 2023-02-23 | ||||||||||||||
| 2020-12-31 | $1.90M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $3.20M derived: sum of 2 quarters · filed 2023-02-23 | $5.38M derived: sum of 3 quarters · filed 2023-02-23 | $6.51M 10-K · filed 2023-02-23 | ||||||||||||||
| 2020-09-30 | $1.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $3.48M derived: sum of 2 quarters · filed 2021-11-09 | $4.61M 10-Q · filed 2021-11-09 | $5.50M derived: sum of 4 quarters · filed 2021-11-09 | ||||||||||||||
| 2020-06-30 | $2.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $3.31M 10-Q · filed 2021-08-11 | $4.20M derived: sum of 3 quarters · filed 2021-08-11 | $5.84M derived: sum of 4 quarters · filed 2021-08-11 | ||||||||||||||
| 2020-03-31 | $1.13M 10-Q · filed 2021-05-12 | $2.02M derived: sum of 2 quarters · filed 2021-05-12 | $3.66M derived: sum of 3 quarters · filed 2021-05-12 | $6.33M derived: sum of 4 quarters · filed 2021-05-12 | ||||||||||||||
| 2019-12-31 | $891.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $2.53M derived: sum of 2 quarters · filed 2021-02-25 | $5.20M derived: sum of 3 quarters · filed 2021-02-25 | $6.20M 10-K · filed 2021-02-25 | ||||||||||||||
| 2019-09-30 | $1.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | $4.31M derived: sum of 2 quarters · filed 2020-11-04 | $5.31M 10-Q · filed 2020-11-04 | $6.45M derived: sum of 4 quarters · filed 2020-11-04 | ||||||||||||||
| 2019-06-30 | $2.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $3.67M 10-Q · filed 2020-08-05 | $4.81M derived: sum of 3 quarters · filed 2020-08-05 | $6.38M derived: sum of 4 quarters · filed 2020-08-05 | ||||||||||||||
| 2019-03-31 | $999.00K 10-Q · filed 2020-05-06 | $2.14M derived: sum of 2 quarters · filed 2020-05-06 | $3.70M derived: sum of 3 quarters · filed 2020-05-06 | $5.91M derived: sum of 4 quarters · filed 2020-05-06 | ||||||||||||||
| 2018-12-31 | $1.14M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $2.71M derived: sum of 2 quarters · filed 2020-02-25 | $4.91M derived: sum of 3 quarters · filed 2020-02-25 | $6.86M 10-K · filed 2020-02-25 | ||||||||||||||
| 2018-09-30 | $1.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $3.77M derived: sum of 2 quarters · filed 2019-11-08 | $5.71M 10-Q · filed 2019-11-08 | $6.80M derived: sum of 4 quarters · filed 2019-11-08 | ||||||||||||||
| 2018-06-30 | $2.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $4.15M 10-Q · filed 2019-08-07 | $5.24M derived: sum of 3 quarters · filed 2019-08-07 | $6.48M derived: sum of 4 quarters · filed 2019-08-07 | ||||||||||||||
| 2018-03-31 | $1.94M 10-Q · filed 2019-05-07 | $3.03M derived: sum of 2 quarters · filed 2019-05-07 | $4.27M derived: sum of 3 quarters · filed 2019-05-07 | $5.52M derived: sum of 4 quarters · filed 2019-05-07 | ||||||||||||||
| 2017-12-31 | $1.08M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $2.33M derived: sum of 2 quarters · filed 2019-02-26 | $3.58M derived: sum of 3 quarters · filed 2019-02-26 | $4.85M 10-K · filed 2019-02-26 | ||||||||||||||
| 2017-09-30 | $1.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $2.50M derived: sum of 2 quarters · filed 2018-11-01 | $3.76M 10-Q · filed 2018-11-01 | $4.77M derived: sum of 4 quarters · filed 2019-02-26 | ||||||||||||||
| 2017-06-30 | $1.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $2.52M 10-Q · filed 2018-08-02 | $3.52M derived: sum of 3 quarters · filed 2019-02-26 | $5.02M derived: sum of 4 quarters · filed 2019-02-26 | ||||||||||||||
| 2017-03-31 | $1.27M 10-Q · filed 2018-05-09 | $2.27M derived: sum of 2 quarters · filed 2019-02-26 | $3.77M derived: sum of 3 quarters · filed 2019-02-26 | $5.13M derived: sum of 4 quarters · filed 2019-02-26 | ||||||||||||||
| 2016-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $2.51M derived: sum of 2 quarters · filed 2019-02-26 | $3.86M derived: sum of 3 quarters · filed 2019-02-26 | $5.13M 10-K · filed 2019-02-26 | ||||||||||||||
| 2016-09-30 | $1.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $2.86M derived: sum of 2 quarters · filed 2017-11-07 | $4.13M 10-Q · filed 2017-11-07 | $6.48M derived: sum of 4 quarters · filed 2018-02-27 | ||||||||||||||
| 2016-06-30 | $1.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | $2.63M 10-Q · filed 2017-08-07 | $4.97M derived: sum of 3 quarters · filed 2018-02-27 | $7.58M derived: sum of 4 quarters · filed 2018-02-27 | ||||||||||||||
| 2016-03-31 | $1.27M 10-Q · filed 2017-05-10 | $3.62M derived: sum of 2 quarters · filed 2018-02-27 | $6.22M derived: sum of 3 quarters · filed 2018-02-27 | $8.00M derived: sum of 4 quarters · filed 2018-02-27 | ||||||||||||||
| 2015-12-31 | $2.35M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $4.95M derived: sum of 2 quarters · filed 2018-02-27 | $6.72M derived: sum of 3 quarters · filed 2018-02-27 | $8.72M 10-K · filed 2018-02-27 | ||||||||||||||
| 2015-09-30 | $2.60M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2016-11-09 | $4.38M derived: sum of 2 quarters · filed 2016-11-09 | $6.38M 10-Q · filed 2016-11-09 | $8.24M derived: sum of 4 quarters · filed 2017-03-16 | ||||||||||||||
| 2015-06-30 | $1.77M derived: 10-Q/A 6 month − 10-Q 3 month · filed 2016-08-10 | $3.78M 10-Q/A · filed 2016-08-10 | $5.64M derived: sum of 3 quarters · filed 2017-03-16 | $817.00K derived: sum of 4 quarters · filed 2017-03-16 | ||||||||||||||
| 2015-03-31 | $2.00M 10-Q · filed 2016-05-09 | $3.87M derived: sum of 2 quarters · filed 2017-03-16 | -$958.00K derived: sum of 3 quarters · filed 2017-03-16 | $39.69M derived: sum of 4 quarters · filed 2017-03-16 | ||||||||||||||
| 2014-12-31 | $1.87M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | -$2.96M derived: sum of 2 quarters · filed 2017-03-16 | $37.69M derived: sum of 3 quarters · filed 2017-03-16 | $48.62M 10-K · filed 2017-03-16 | ||||||||||||||
| 2014-09-30 | -$4.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $35.82M derived: sum of 2 quarters · filed 2015-11-09 | $46.76M 10-Q · filed 2015-11-09 | $60.64M derived: sum of 4 quarters · filed 2016-03-15 | $229.86M 10-Q · filed 2014-11-10 | |||||||||||||
| 2014-06-30 | $40.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $51.58M 10-Q · filed 2015-08-10 | $65.47M derived: sum of 3 quarters · filed 2016-03-15 | $81.41M derived: sum of 4 quarters · filed 2016-03-15 | $234.69M 10-Q · filed 2014-08-11 | |||||||||||||
| 2014-03-31 | $10.94M 10-Q · filed 2015-05-11 | $24.82M derived: sum of 2 quarters · filed 2016-03-15 | $40.76M derived: sum of 3 quarters · filed 2016-03-15 | $50.93M derived: sum of 4 quarters · filed 2016-03-15 | $194.04M 10-Q · filed 2014-05-12 | |||||||||||||
| 2013-12-31 | $13.88M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $29.82M derived: sum of 2 quarters · filed 2016-03-15 | $40.00M derived: sum of 3 quarters · filed 2016-03-15 | $45.19M 10-K · filed 2016-03-15 | $183.10M 10-K · filed 2014-03-03 | |||||||||||||
| 2013-09-30 | $15.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $26.11M derived: sum of 2 quarters · filed 2014-11-10 | $31.30M 10-Q · filed 2014-11-10 | $34.83M derived: sum of 4 quarters · filed 2015-03-02 | $169.22M 10-Q · filed 2013-11-12 | |||||||||||||
| 2013-06-30 | $10.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | $15.36M 10-Q · filed 2014-08-11 | $18.88M derived: sum of 3 quarters · filed 2015-03-02 | $22.70M derived: sum of 4 quarters · filed 2015-03-02 | $153.28M 10-Q · filed 2013-08-09 | |||||||||||||
| 2013-03-31 | $5.19M 10-Q · filed 2014-05-12 | $8.71M derived: sum of 2 quarters · filed 2015-03-02 | $12.53M derived: sum of 3 quarters · filed 2015-03-02 | $15.60M derived: sum of 4 quarters · filed 2015-03-02 | $143.11M 10-Q · filed 2013-05-10 | |||||||||||||
| 2012-12-31 | $3.52M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $7.34M derived: sum of 2 quarters · filed 2015-03-02 | $10.41M derived: sum of 3 quarters · filed 2015-03-02 | $13.29M 10-K · filed 2015-03-02 | $137.92M 10-K · filed 2013-03-18 | |||||||||||||
| 2012-09-30 | $3.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $6.89M derived: sum of 2 quarters · filed 2013-11-12 | $9.77M 10-Q · filed 2013-11-12 | $12.95M derived: sum of 4 quarters · filed 2014-03-03 | $134.40M 10-Q · filed 2012-11-09 | |||||||||||||
| 2012-06-30 | $3.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $5.95M 10-Q · filed 2013-08-09 | $9.13M derived: sum of 3 quarters · filed 2014-03-03 | $12.45M derived: sum of 4 quarters · filed 2014-03-03 | $130.58M 10-Q · filed 2012-08-09 | |||||||||||||
| 2012-03-31 | $2.88M 10-Q · filed 2013-05-10 | $6.06M derived: sum of 2 quarters · filed 2014-03-03 | $9.38M derived: sum of 3 quarters · filed 2014-03-03 | $11.37M derived: sum of 4 quarters · filed 2014-03-03 | $127.50M 10-Q · filed 2012-05-10 | |||||||||||||
| 2011-12-31 | $3.18M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | $6.50M derived: sum of 2 quarters · filed 2014-03-03 | $8.50M derived: sum of 3 quarters · filed 2014-03-03 | $11.20M 10-K · filed 2014-03-03 | $124.63M 10-K · filed 2012-03-15 | |||||||||||||
| 2011-09-30 | $3.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $5.32M derived: sum of 2 quarters · filed 2012-11-09 | $8.02M 10-Q · filed 2012-11-09 | $10.26M derived: sum of 4 quarters · filed 2013-03-18 | $121.44M 10-Q · filed 2011-11-04 | |||||||||||||
| 2011-06-30 | $1.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | $4.70M 10-Q · filed 2012-08-09 | $6.94M derived: sum of 3 quarters · filed 2013-03-18 | $10.28M derived: sum of 4 quarters · filed 2013-03-18 | $118.12M 10-Q · filed 2011-08-04 | |||||||||||||
| 2011-03-31 | $2.71M 10-Q · filed 2012-05-10 | $4.95M derived: sum of 2 quarters · filed 2013-03-18 | $8.28M derived: sum of 3 quarters · filed 2013-03-18 | |||||||||||||||
| 2010-12-31 | $2.24M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $5.58M derived: sum of 2 quarters · filed 2013-03-18 | $13.58M 10-K · filed 2013-03-18 | |||||||||||||||
| 2010-09-30 | $3.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04 | $11.34M 10-Q · filed 2011-11-04 | ||||||||||||||||
| 2010-06-30 | $8.01M 10-Q · filed 2011-08-04 | |||||||||||||||||
| 2009-12-31 | $20.22M 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |